Cas:879893-98-8 (3-Amino-4-methoxyphenyl)boronic acid manufacturer & supplier

We serve Chemical Name:(3-Amino-4-methoxyphenyl)boronic acid CAS:879893-98-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

(3-Amino-4-methoxyphenyl)boronic acid

Chemical Name:(3-Amino-4-methoxyphenyl)boronic acid
CAS.NO:879893-98-8
Synonyms:(3-amino-4-methoxyphenyl)boronic acid
Molecular Formula:C7H10BNO3
Molecular Weight:166.97000
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:387.1ºC at 760 mmHg
Density:1.25g/cm3
Index of Refraction:1.564
PSA:75.71000
Exact Mass:167.07500
LogP:

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3-amino-4-methoxyphenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(3-amino-4-methoxyphenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(3-amino-4-methoxyphenyl)boronic acid Use and application,(3-amino-4-methoxyphenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. (3-Amino-4-methoxyphenyl)boronic acid manufacturer Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers. (3-Amino-4-methoxyphenyl)boronic acid supplier Any US citizen who has been in China’s Hubei province — epicenter of the outbreak — in the last 14 days will be allowed back into the country. (3-Amino-4-methoxyphenyl)boronic acid vendor Biogen last month revived its plans to seek U.S. approval for its aducanumab treatment after announcing in March that it would terminate two large clinical trials for the drug. But some analysts believed FDA approval is highly unlikely. (3-Amino-4-methoxyphenyl)boronic acid factory Among them, Zhejiang pharmaceutical companies accounted for 4 of the world’s top ten API manufacturers.